pharmaphorum

JANUARY 8, 2021

According to one analysis, conducted by Global Data, approximately 67% of trial disruptions during the early stages of the pandemic were due to the suspension of enrolment, followed by the delayed start of planned trials at 18.4% How can pharma improve the patient-centricity of its trials during COVID-19 and beyond?

Trials 105

Trials Research Clinical Trials Clinical Trials 105

pharmaphorum

OCTOBER 27, 2022

Ipsen’s Dr Oleksandr Gorbenko and MediPaCe’s Dr Sandeep Bagga examine the ‘impact’ of engaging with patients and how patients view their experiences of discussing impact measurement with life science companies. The concept of patient centricity has been a key talking point across the healthcare ecosystem for years.

Life Science 105

Life Science Research Development Clinical Research 105

pharmaphorum

NOVEMBER 23, 2022

But when viewed in isolation, these robust data sets may only provide HTA bodies with a blinkered view of the broader impact of an intervention. Traditionally, HTA submissions leverage significant amounts of data: data about cost, clinical efficacy, benefits, and risks.

52

52

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors.

Clinical Trials 130

Clinical Trials Clinical Trials Trials Dermatology 130

ACRP blog

JULY 26, 2022

ICH E9 provides guidance on the design, conduct, analysis, and evaluation of clinical trials of an investigational product in the context of its overall clinical development. View Details & Sign Up > The ICH E9 addendum (R1) provides clarification on some of the concepts explained in ICH E9, Frestedt says. The bad news?

Trials 105

Trials Clinical Trials Clinical Trials Clinical Development 105

World of DTC Marketing

OCTOBER 30, 2020

PAGES VIEWED. However, in a deeper analysis, we have found that each page’s time is too short to read its entire content. WHAT’S DRIVING TRAFFIC: My analysis of traffic indicates that the vast majority of traffic is coming from Google. 3hree: A/B testing on different home page concepts.

Branding 279

Branding Marketing Development Research 279

pharmaphorum

OCTOBER 20, 2022

Historically, competitive and market analysis data has been stored in spreadsheets. Executing an effective commercial success strategy requires extensive planning and implementation within pharmaceutical companies that spans teams, functions, and geographies.

Branding 98

Branding Marketing Production Pharma Companies 98

pharmaphorum

APRIL 30, 2021

A recent analysis delves into the challenges companies face in getting digital health technologies reimbursed and presents recommendations for how they can find a smoother path to market. Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage. Time for a NICE change.

Marketing 98

Marketing Sales Regulation Drugs 98

Cloudbyz

NOVEMBER 1, 2023

Monitoring and assessing the safety of these products involves the collection, analysis, and reporting of adverse events and drug reactions. MedDRA integration facilitates the systematic analysis of data related to specific adverse events, making it easier to identify potential safety concerns.

Compliance 94

Compliance Drugs Production Regulation 94

pharmaphorum

OCTOBER 26, 2020

A new analysis looks at these barriers and asks how they could be overcome. Understanding payer views of preventive care. Preventive care programmes are key to better health outcomes, but several factors are limiting their uptake.

Life Science 129

Life Science Genetics Development Vaccination 129

pharmaphorum

DECEMBER 7, 2022

Source: CT assessments [Haute Autorité de Santé website]; ANSM [Agence Nationale de Sécurité du Médicament et des Produits de Santé]; CRA analysis). Pricing and market access in France operate on a dual system, under which health technology assessments (HTAs) are conducted separately from pricing negotiations. Rare diseases: a flawed system.

Drugs 104

Drugs Life Science Production Manufacturing 104

World of DTC Marketing

MARCH 7, 2022

Click-stream analysis can be critical. 2wo: How long are they staying on your site, and what pages get the most views? 2wo: How long are they staying on your site, and what pages get the most views? One of our most frequent requests is to analyze small biotech websites. Too many try to say too much with too much copy.

Clinical Trials 180

Clinical Trials Clinical Trials Trials Marketing 180

Pharmaceutical Technology

AUGUST 4, 2022

Business optimism declined in July 2022 compared to June 2022, amid concerns over inflation as the cost-of-living pressures on households continued to grow in countries such as the UK, revealed the analysis of an ongoing poll by Verdict. Business confidence falls three points to 25% in the UK. believed it would decrease. in market services.

Manufacturing 130

Manufacturing Marketing 130

World of DTC Marketing

NOVEMBER 12, 2021

One of the services that I provide is an in-depth analysis of clients’ websites, including analytics. 2wo: Time on site and pages viewed remain very low. 2wo: Time on site and pages viewed remain very low. 5ive : In-depth analysis of content still shows it to be at a college-level reading level.

Branding 180

Branding Marketing Production Pharma Production 180

pharmaphorum

AUGUST 4, 2020

A new analysis from consulting firm CRA has honed in on the different challenges faced in four European markets – England, France, Germany and Scotland – and looked at how manufacturers can increase the chances of a successful appraisal. Source: CRA Analysis. Rates of approval.

Drugs 121

Drugs Manufacturing Marketing Regulation 121

World of DTC Marketing

JANUARY 21, 2021

3hree : Average page views were 2.6. 5ive: Clickstream analysis indicated that visitors came from Google via organic search. When I speak to a client about an analysis of their website, the first question I ask after the analysis, is “how much time and money did you spend in developing the site? in 2008 to 38.5%

Production 180

Production Branding Pharma Companies Development 180

pharmaphorum

DECEMBER 17, 2021

pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Digital health: making medicine more human. Driving transformation and innovation in healthcare.

Clinical Trials 98

Clinical Trials Clinical Trials Medicine DNA 98

Pharmaceutical Technology

JULY 6, 2022

Business optimism improved in June 2022 compared to May 2022, even amid concerns over rising costs and slowing demand, revealed an analysis of an ongoing poll by Verdict. Analysis of the poll responses recorded in June 2022 shows that optimism regarding future growth prospects increased by five percentage points to 63% from 58% in May 2022.

Manufacturing 130

Manufacturing Production Sales Marketing 130

WCG Clinical

MARCH 17, 2023

With many clinical research sites facing study start-up delays and backlogs, performing a coverage analysis efficiently and thoroughly is critical to the study start-up process. But why is the coverage analysis process so vital for clinical trials and how can research sites do it more effectively?

Compliance 52

Compliance Clinical Trials Clinical Trials Trials 52

pharmaphorum

AUGUST 19, 2021

The Good Clinical Trials Collaborative (GCTC) has published a draft guidance document, and is asking for the life sciences sector to make its views known. A common set of standards for randomised clinical trials (RCTs) aims to help researchers develop the drugs and interventions of the future – no matter what they do or where they are based.

Trials 105

Trials Clinical Trials Clinical Trials Life Science 105

pharmaphorum

JANUARY 24, 2022

A private equity group has agreed to take over most of IBM Watson Health, seven years after the business was launched with a pledge to revolutionise healthcare data analysis. IBM said it “remains committed to Watson, our broader AI business, and to the clients and partners we support in healthcare IT.”

Radiology 110

Radiology Marketing Genome Genomics 110

Pharmaceutical Technology

JULY 12, 2022

GlobalData views the ALL pipeline as unsustainable given the rarity of the disease and, unfortunately, most of the pipeline CAR-T cell products for ALL will never reach the market due to strategic decisions, potentially prioritizing other cancers.

Clinical Development 130

Clinical Development Development Production Sales 130

Drug Discovery World

OCTOBER 26, 2023

Transcriptomics, an unbiased approach to quantify mRNAs in a sample, is an excellent method to generate highly multidimensional functional readouts from biological material, thus giving a precise view on the state of cells and organs, while being highly scalable and economical.

Drugs 52

Drugs Protein Genome Genomics 52

pharmaphorum

SEPTEMBER 27, 2021

An analysis of FDA data into trials of cancer drugs approved since 2015 found that 24 out of 31 cancer drug trials had fewer than 5% black trial participants – and this is despite black women being disproportionately affected. This already significant industry is growing – it is estimated to be worth $1.27 trillion by end of 2020.

Clinical Trials 121

Clinical Trials Clinical Trials Trials Vaccination 121

pharmaphorum

JULY 7, 2022

pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Eradicating cancer is an ambitious goal for oncologists and life science companies around the world.

Vaccination 52

Vaccination Vaccine Life Science Trials 52

pharmaphorum

NOVEMBER 11, 2020

Other promising benefits include administrative automation and population health risk analysis. AI based diagnostic image analysis is showing a lot of promise. Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment.

Engineer 139

Engineer Life Science Genome Genomics 139

World of DTC Marketing

AUGUST 25, 2021

However, clickstream analysis via Alexa clearly shows that TV ads also lead to searches for competitive treatments. Prescription drugs for depression should take an empathetic view but should not over-promise. So let’s get right to it. 1ne: Should we change budget allocations by channel? First, there is no one right answer.

Marketing 154

Marketing Production Drugs Doctors 154

pharmaphorum

FEBRUARY 11, 2022

It’s our representation of tracking the deidentified, which is important from a privacy and compliance point of view,” Sun says. “It Though 7,000 rare diseases exist that affect 400 million people globally, a lack of understanding of these diseases can cause a delay in diagnosis and, in turn, treatment. The benefits of accessibility.

Life Science 104

Life Science Engineer Development Big Data 104

pharmaphorum

OCTOBER 28, 2021

Three views on technology improving clinical trial efficiency. pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Time for a new model in patient access.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

pharmaphorum

JUNE 2, 2021

As more cases were reported and various health stakeholders around the world recommended or discouraged use of the vaccine, HCPs used social media as a platform to make their views known. The formation of blood clots is a necessary process in order for the body to repair damage caused by injury and to slow down bleeding.

Vaccination 105

Vaccination Vaccine Development Medicine 105

Rethinking Clinical Trials

JUNE 29, 2022

Real-world evidence (RWE) is clinical evidence derived from analysis of RWD regardless of study design. From the FDA point-of-view, while reliability can be more readily evaluated and would tend to be more stable, the relevance to a particular study could not be determined as easily. Office of Medical Policy (OMP). Key Points.

Big Data 130

Big Data Clinical Trials Clinical Trials Drugs 130

pharmaphorum

MARCH 11, 2021

View the webinar* by clicking on the link in the window above or by clicking here. View the webinar* by clicking on the link in the window above or by clicking here. An important source of RWE has, until recently, been locked in the electronic health record (EHR). Deep RWE in practice – early results from the BigCOVIData study.

Big Data 109

Big Data Clinical Trials Clinical Trials Research 109

World of DTC Marketing

DECEMBER 2, 2021

Some of these studies associated information seeking more strongly with patients with chronic conditions and those with a more positive view of DTC advertising. It involves many steps, and DTC marketers should develop a decision tree analysis of what their audience does due to seeing one of their ads.

Drugs 185

Drugs Doctors Doctor Research 185

pharmaphorum

NOVEMBER 2, 2020

This is a content standard that ensures clinical data is submitted in a consistent manner, helping to reduce review time and facilitating cross-study analysis. Another content standard, the Analysis Data Model (ADaM), aims to perform a similar function for analysis datasets. ADaM – standardizing analysis datasets.

Compliance 98

Compliance Regulation Clinical Trials Clinical Trials 98

pharmaphorum

APRIL 21, 2022

Although beneficial in many ways, this activity-driven approach by its very nature creates a limited view of KOLs which is based primarily on their past activity. Although beneficial in many ways, this activity-driven approach by its very nature creates a limited view of KOLs which is based primarily on their past activity.

Branding 52

Branding Production Trials 52

pharmaphorum

MAY 6, 2022

pharmaphorum’s digital magazine Deep Dive provides objective, issue-driven views, analysis, high-level interviews and unique research for pharmaceutical companies, biotech firms and the wider healthcare sector. Closing the digital expectation gap in pharma. Combination pricing: access to the future of oncology treatment.

Marketing 52

Marketing Life Science Regulation Development 52

World of DTC Marketing

MARCH 22, 2021

Your goal is that pesky engagement word and can be measured by return visitors and an analysis of the pages they viewed beyond coupons for discounts. Your goal is that pesky engagement word and can be measured by return visitors and an analysis of the pages they viewed beyond coupons for discounts.

Pharma Production 261

Pharma Production Production Marketing Doctors 261